↗ https://reddit.com/r/investing/comments/1s9ebo3/is_novo_nordisk_the_new_intel_when_high_roe_meets/
Looking at the recent posts about Novo Nordisk's 0.56 P/S and 10x Forward P/E, the consensus seems to be that the market is "pricing in the death of the company." However, value usually only gets this cheap if there's a structural belief that earnings will permanently decline. What do you guys think? Yes I have some investments in NVO :(